Picture of Enorama Pharma AB logo

ERMA — Enorama Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Enorama Pharma Gets Objection To Swedish Patent

May 26 (Reuters) - Enorama Pharma AB  ERMA.ST :  
    * SAID ON MONDAY HAS RECEIVED AN OBJECTION TO THE SWEDISH
PATENT
FOR NICOTINE CHEWING GUM FORMULATION
    * SAYS FERTIN PHARMA MADE THE OBJECTION
    * OBJECTION PROCESS NORMALLY LASTS 12-24 MONTHS

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr4kXmHT
    
 Further company coverage:  ERMA.ST  
   
    
    

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Enorama Pharma AB

See all news